AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Spinal Decompression Plus Nerve Graft Implantation Following TSCI

RecruitingNAAges 18 Years - 80 YearsAllFrancis Farhadi
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is a single-blinded (with outcome assessors blinded to treatment allocation), 12-month pilot study to evaluate of the safety, feasibility, and preliminary efficacy of dorsal myelotomy and expansive duraplasty performed either without or with autologous nerve graft implantation after acute traumatic spinal cord injury. Ten participants will be allocated to receive either DMED (n=5) or DMED + ANGI (n=5) based on a block design. Participants and assessors will be blinded to group allocation. Excess sural nerve samples will be collected for banking/analysis (may include proteomic, culturing, genomic, cellular analysis).

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age: = 18 years and = 80 years * Written informed consent by patient or legal authorized representative * No other life-threatening injury * No evidence of sepsis * Acute cervical or thoracic SCI with ASIA Impairment Scale grade A or B on admission * Non-penetrating SCI at neurologic level from C2 to C8 or T1 to T12 * The ability to undergo surgical intervention including study procedures through a posterior approach within 48 hours of injury Exclusion Criteria: * Unconsciousness or other mental impairment that prevents neurological assessment within the first 48 hours * Acute SCI with ASIA Impairment Scale grade C, D or E * Spinal cord decompression and spinal stabilization can be safely performed through an anterior-only approach (i.e. posterior approach is not required) * Currently involved in another non-observational SCI research study or receiving another investigational drug * Other illness (including mental disorder) that could preclude accurate medical and neurological evaluation (at discretion of the principal investigator) * Unable to commit to the follow-up schedule * A recent history of regular substance abuse (illicit drugs, alcohol), which in the opinion of the investigator would interfere with the subject's participation in the study * Any condition likely to result in the patient's death within the next 12 months * Prisoner * Subjects who in the opinion of the investigator are not suitable for inclusion in the study (reason to be documented). * Pregnancy
๐Ÿ’Š

What it tests

  • DMED
  • ANGI
๐Ÿ“

Where

1 site
University of Kentucky - Chandler Medical Center
Lexington, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy